Hodgkin\'s Disease
author
Abstract:
SUMMARY Hodgkin's disease has been known to medical practitioners for more than three centuries. The clinical and pathologic description of the disease published by Thomas. Hodgkin first in 183 2 when reported seven cases th-at he considered a new clinical entity. The incident, clinical feature, histologic, procedure of evaluation and staging of Hodgkin's disease are presented briefly. Particular attention to histopathology with the reference to the characteristics of Reed - Sternberg cells and staging of the disease is emphasized. The management of Hodgkin's disease is reviewed in more details. Hodgkin's disease may now be managed with several different regimens with expectation of curing approximately 80 - 90 percent of patients. Radiotherapy alone achieves this cure rate only in unilateral highcevical or inguinal stage 1 and certain faivorable histological stage 2 presentation. Combination chemotherapy not only helps to irradiation therapy to the patients with stage 2 & 3 and those suffering from mediastinal involvement. It has cured nearly 7 percent of patients with for advanced Hodgkin's disease. Autologous bone marrow transplantation recently offers a considerable hopes in patients with relapsed Hodgkin's disease. The outlook for patients with Hodgkin's disease has improved dramatically over the post twenty years. The goal of curing all patient with Hodgkin's disease would seem to be within reach. Although much remains to be elucidated in the biology of Hodgkin's disease, highly effective treatment is now available for all stages and disease presentations. The goal is to cure all patients while minimizing morbidity in near future.
similar resources
Viral-related RNA in Hodgkins' disease and other human lymphomas.
Molecular hybridization with radioactively labeled DNA complementary to the RNA of the Rauscher leukemia virus was used to probe for homologous RNA in human lymphomas. 22 of 32 specimens contained RNA possessing homology to the RNA of the mouse leukemia virus, but not to that of the unrelated viruses causing mammary tumors in mice or myeloblastosis in chickens. Normal adult and fetal tissues fa...
full textMotor neuron disease and its association with non-Hodgkins lymphoma.
M otor neuron disease (MND) is a neurodegenerative disorder characterized by muscle atrophy, brisk reflexes, spasticity, fasciculation, and atrophy. The onset of the disease is generally insidious. The pathological process may involve the motor cortex, the spinal cord, and the brainstem. 1 Only upper or only lower motor neurons may be affected. The disease may or may not be seen with neoplasms,...
full textCurrent strategies in the treatment of childhood Hodgkins disease.
Dramatic changes in the treatment of childhood Hodgkins disease have taken place during the past three decades. Contemporary combined modality treatment regimens produce durable disease-free survival in 90 to 100%of patients with early disease and in 70 to 85%of patients with advanced disease. Studies using chemotherapy alone also report high survival rates, and current studies are few to highl...
full textNon-Hodgkins Lymphoma presenting as Garcin’s Syndrome
An 80 year old man presented with a twelve month history of progressive multiple unilateral cranial nerve palsies. A gadolinium enhanced MRI scan of his head and neck was performed. This showed an extra-axial enhancing lesion, which enveloped the hemi-mandible at the level of the left inferior alveolar nerve, and a dumbbell shaped lesion within the cerebellopontine angle. An incisional biopsy w...
full textHodgkins lymphoma with HIV infection.
The association between Hodgkins Lymphoma (HL) with HIV is common in adults but rare in children. A 5 year old boy, known case of HIV on antiretroviral therapy, presented with prolonged fever, multiple enlarged lymph nodes along with hepatosplenomegaly. A diagnosis of Hodgkins lymphoma was entertained on histopathological examination; further subtyping was done by immunohistochemistry.
full textHodgkins lymphoma: treatment and prognosis
Supported in part by a grant provided by IASIS a non-profit organization raising funds for Research in Leukemias, Lymphomas and related disorders come. AAS I/IIA are definitely non-advanced for most study groups. Non-advanced stages are further classified as early or early favourable and intermediate or early unfavourable according to the presence of adverse features. Table 1 summariz...
full textMy Resources
Journal title
volume 12 issue 3
pages 145- 159
publication date 1988-09
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023